GlassScriptPhysician profile
Aida A Behani
NPI 1144483363
$356.35
in general payments reported to CMS, 2019-2025
12 companies · $48.85 in 2025
The $48.85 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.18 · 2020: $72.65 · 2021: $30.46 · 2022: $21.74 · 2023: $90.84 · 2024: $19.63 · 2025: $48.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $159.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $57.21 | 2019-2021 | |
| Voco America INC. | $45.90 | 2023 | Profluorid L, Voco Profluorid Varnish |
| Phadia US INC. | $45.27 | 2019-2023 | Immunocap |
| Merck Sharp & Dohme LLC | $44.08 | 2019-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Exact Sciences Corporation | $28.78 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $28.48 | 2020-2021 | |
| Indivior INC. | $22.77 | 2023 | Sublocade |
| Gilead Sciences, INC. | $21.74 | 2022 | |
| Pfizer INC. | $19.63 | 2024 | |
| Qol Medical, LLC | $16.18 | 2019 | |
| Sanofi Pasteur INC. | $14.72 | 2020 | |
| Antares Pharma, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aida Behani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.